NEUROENDOCRINE CANCER
Clinical trials for NEUROENDOCRINE CANCER explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE CANCER trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ZG006 targets tough lung cancers in early trial
Disease control Recruiting nowThis study tests a new drug called ZG006 in people with advanced small cell lung cancer or neuroendocrine carcinoma. The first part finds a safe dose, and the second part checks how well that dose shrinks tumors. About 265 adults aged 18-75 with good performance status are being …
Matched conditions: NEUROENDOCRINE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New drug BL-M14D1 targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called BL-M14D1 in people with advanced small cell lung cancer or other neuroendocrine cancers that have spread. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. About 120 adults will take part.
Matched conditions: NEUROENDOCRINE CANCER
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New PET tracer could spot hidden neuroendocrine tumors
Diagnosis Recruiting nowThis study is testing a new imaging tracer that targets a protein called DLL3, found on some neuroendocrine cancer cells. The goal is to see if this special PET/CT scan can find tumors better than standard scans. About 60 adults with suspected or confirmed neuroendocrine cancer w…
Matched conditions: NEUROENDOCRINE CANCER
Phase: NA • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated May 17, 2026 04:33 UTC